Back
Beyond Meat, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
34
BYND
Beyond Meat, Inc.
Last Price:
$1.04
Seasonality Move:
-5.55%
Sell
36
MNPR
Monopar Therapeutics, Inc.
Last Price:
$65.21
Seasonality Move:
9.84%
Sell
34
Beyond Meat, Inc. (BYND)
is a Sell
Is Beyond Meat, Inc. a Buy, Sell or Hold?
-
The current Beyond Meat, Inc. [BYND] share price is $0.93. The Score for BYND is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
BYND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $61.07. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BYND Stock Price Chart
What is Beyond Meat, Inc.'s stock price today?
-
The Beyond Meat, Inc. share price today is $0.93The current trend is relatively stagnant and BYND is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $61.07Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BYND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 43.12 | Sell |
| Chaikin Money Flow: | 21620971 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.93 - 1.23) | Sell |
| Bollinger Bands (100): | (1.02 - 2.58) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.47 | Sell |
| Relative Strength Index (14 RSI): | 30.39 | Sell |
| Chaikin Money Flow: | 259147 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.05 - 78.95) | Sell |
| Bollinger Bands (100): | (50.05 - 89.79) | Sell |
BYND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Buy |
| 20-day SMA: | 1.05 | Sell |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 2.44 | Sell |
| 8-day EMA: | 0.92 | Buy |
| 20-day EMA: | 1.01 | Sell |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 2.48 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.1 | Sell |
| 20-day SMA: | 70.54 | Sell |
| 50-day SMA: | 78.02 | Sell |
| 200-day SMA: | 53.9 | Buy |
| 8-day EMA: | 65.23 | Sell |
| 20-day EMA: | 69.87 | Sell |
| 50-day EMA: | 73.61 | Sell |
| 200-day EMA: | 57.53 | Buy |
Beyond Meat, Inc. Earnings Growth & BYND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.22 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.34 per share.
Beyond Meat, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||